Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models

Exploring the mechanism of Taohong Siwu decoction in the treatment of hyperlipidemia based on network pharmacology and zebrafish models

Introduction: Taohong Siwu Decoction (TSD) is a traditional Chinese medicine used to treat cardiovascular diseases and blood stasis. This study explores the therapeutic mechanisms of TSD in treating hyperlipidemia using a network pharmacology approach combined with a zebrafish hyperlipidemia model....

Full description

Saved in:

Bibliographic Details
Main Authors:	Mingyang Li, Xinmei Zhang, Chunyue Bao, Fan Li, Yulong Wu, Guangming Huo, Chuanfeng Tang, Jianmei Li
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	Pharmacological Research - Modern Chinese Medicine
Subjects:	Taohong Siwu decoction Hyperlipidemia Network pharmacology Zebrafish models
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667142525000296
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-targeted metabolomics and network pharmacology of Taohong Siwu Decoction in hepatic fibrosis mouse model using high resolution mass spectrometry
by: Shengsheng Li, et al.
Published: (2025-06-01)

Effects of Taohong Siwu Decoction on renal protection and ERK1/2/HIF-1α signaling pathway in rats with mesangial proliferative glomerulonephritis
by: Wu Xue-bing, et al.
Published: (2022-02-01)

Siwu decoction mitigates radiation-induced immune senescence by attenuating hematopoietic damage
by: Mingyue Huang, et al.
Published: (2024-12-01)

Dose-Weighted Network Pharmacology: Evaluating Traditional Chinese Medicine Formulations for Lumbar Disc Herniation
by: Zhou C, et al.
Published: (2025-01-01)

The effect of the Hippocampus erectus decoction on improving osteoporosis in zebrafish
by: Qiuxian Chen, et al.
Published: (2024-12-01)

Pro-angiogenic effects of Guo Min decoction in a zebrafish model
by: Ping-Hsun Lu, et al.
Published: (2025-01-01)

Pro-angiogenic effects of Guo Min decoction in a zebrafish model
by: Ping-Hsun Lu, et al.
Published: (2025-01-01)

Alleviating effect of Lactobacillus fermentum E15 on hyperlipidemia and hepatic lipid metabolism in zebrafish fed by a high-fat diet through the production of short-chain fatty acids
by: Yishu Chen, et al.
Published: (2025-03-01)

Network pharmacology-based study on the mechanism of Yiwei Decoction in chronic atrophic gastritis and experimental assessment
by: Zepeng Zhang, et al.
Published: (2024-12-01)

Hyperlipidemia and atherosclerosis: experimental models
by: K. I. Davletova, et al.
Published: (2025-07-01)

Deciphering the angiogenic potential of Zhishi Xiebai Guizhi decoction in coronary heart disease: an in-depth network pharmacology and experimental investigation
by: Yingli Mo, et al.
Published: (2025-07-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

Safety and Efficacy of Inclisiran in Hyperlipidemia: An Updated Meta‐Analysis of Randomised Controlled Trials
by: Jawad Basit, et al.
Published: (2025-03-01)

Do symptoms arise from hyperlipidemia due to hyperviscosity or through its atherosclerotic consequences? – A case series exploration
by: Amit Chakraborty, et al.
Published: (2025-08-01)

Mechanisms of Microctis Folium in Hyperlipidemia: Integrating Serum Pharmacochemistry, Network Pharmacology, and Transcriptomics
by: Xiao G, et al.
Published: (2025-07-01)

Taohong Siwu Decoction Combined With the LncRNA H19/miR-675-5p Axis Repairs Limb Ischemia-Reperfusion Injury Through the Regulation of the Wnt3a/Ca2+ Signaling Pathway
by: Fuping Zhu, et al.
Published: (2025-01-01)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
by: Rebecca M. Yim, et al.
Published: (2023-03-01)

Association between hyperlipidemia and postoperative delirium risk: a systematic review and meta-analysis
by: Li-quan Qiu, et al.
Published: (2025-03-01)

Lipid droplet accumulation impairs osseointegration by disturbing the osteogenesis-osteoclasis balance on titanium implant surface in hyperlipidemia
by: Ya-nan Wang, et al.
Published: (2025-05-01)

Occurrence of hyperlipidemia in relation to body mass index in school children aged 9–11
by: Łukasz Szternel, et al.
Published: (2015-12-01)

Optimization extraction process of Shenghua Decoction and evaluation of its analgesic effects
by: Zhonghui Pu, et al.
Published: (2025-01-01)

Research Progress and Prospects of Flavonoids in the Treatment of Hyperlipidemia: A Narrative Review
by: Xingtong Chen, et al.
Published: (2025-07-01)

Hypolipidemic Effect and Mechanism of Bifidobacterium animalis NX-6 on a Zebrafish Model of Hyperlipidemia
by: HE Yingxi, XU Xinzhu, LIN Shuxian, SHENG Wen, XU Suhua, GUO Lina
Published: (2025-07-01)

Zebrafish Embryo as an Emerging Model Organism in Neurodevelopmental Toxicity Research
by: Şükriye Çalışkan, et al.
Published: (2021-12-01)

Meta-analysis of the effects of probiotics on hyperlipidemia
by: Yuanyue Yao, et al.
Published: (2024-01-01)

Characterization and Nutritional Intervention Effects of <i>Canna edulis</i> Type 5 Resistant Starch in Hyperlipidemia Mice
by: Houxier Li, et al.
Published: (2025-01-01)

Gut Microbiota-Targeted Intervention of Hyperlipidemia Using <i>Monascus</i>-Fermented Ginseng
by: Qing Zhou, et al.
Published: (2025-04-01)

Probiotics for the treatment of hyperlipidemia: Focus on gut-liver axis and lipid metabolism
by: Min You, et al.
Published: (2025-04-01)

Protective effect of Lyophyllum ulmarium fibrolytic enzyme on liver injury induced in hyperlipidemia rats
by: LI Yu, et al.
Published: (2023-06-01)

EFFECTS OF LUDARTIN AND LEUKOMISIN ON THE ACUTE HYPERLIPIDEMIA MODEL INDUCED BY ETHANOL
by: A. V. Ratkin, et al.
Published: (2015-08-01)

EFFECTS OF GROSSHEMIN AND GROSSMISIN ON THE ACUTE HYPERLIPIDEMIA MODEL INDUCED BY ETHANOL
by: A. V. Ratkin, et al.
Published: (2014-02-01)

HYPOLIPIDEMIC EFFECT LEUCOMISINE MODEL OF ACUTE HYPERLIPIDEMIA INDUCED BY ETHANOL
by: E. A. Rodnova, et al.
Published: (2013-02-01)

Automated process assessment of primary healthcare for hyperlipidemia: preliminary findings and implications form Anhui, China
by: Ningjing Yang, et al.
Published: (2025-01-01)

Effects of the aqueous extract from Abelmoschus esculentus L peel on hyperglycemia and hyperlipidemia induced by dexamethasone in rats
by: Aisha Dugani, et al.
Published: (2018-01-01)

Effect of Alcoholic Catechin Extract on Hyperglycemia, Hyperlipidemia and Liver Functions in Alloxan Diabetic Mice
by: Baghdad Science Journal
Published: (2014-09-01)

A Case Report of IgA‐κ Type Multiple Myeloma Complicated With Hyperlipidemia
by: Jie Li, et al.
Published: (2025-04-01)

Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of Guben Xiezhuo decoction against renal fibrosis
by: Shutao Chen, et al.
Published: (2025-08-01)

Diabetes Mellitus and Hyperlipidemia Status Among Hypertensive Patients in the Community and Influencing Factors Analysis of Blood Pressure Control
by: Shijia Zhang, et al.
Published: (2025-02-01)

Familial combined hyperlipidemia: current status of the problem (literature review)
by: O. V. Timoshchenko, et al.
Published: (2024-10-01)

Secondary hyperlipidemias: etiology and pathogenesis
by: A. I. Ershova, et al.
Published: (2019-06-01)